New treatment modality for amyloidosis related diseases – Vermilion Therapeutics

Developing a promising therapeutic technology which may contribute to treat various amyloidosis related diseases, incl. Alzheimer’s Disease. Venture Valuation (VV) interviewed TORII Shin-ichi, Ph.D., founder and CEO. Read the Interview Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?

Read more

Heartseed Inc., Breakthrough cell therapy for severe heart failure.

As an innovative new treatment option for heart failure, a unique cardiac remuscularization therapy has been invented by Dr. FUKUDA Keiichi, Founder & CEO, Professor at Keio University School of Medicine. Venture Valuation (VV) interviewed YASUI Kikuo, COO. Read the Interview Would you like to be notified about new interviews, reports and other valuable content … Continue reading Heartseed Inc., Breakthrough cell therapy for severe heart failure.

Read more

How to assess start-up companies

Relevant soft factors to assess startup companies Investing in early-stage companies is a risky business. Many venture capitalists have fallen victim to the consequences of a myopic attitude towards thorough risk assessments. Although the negative experiences tend to be heard first, it’s the success stories that make it all the more worthwhile. Before taking the … Continue reading How to assess start-up companies

Read more

Yone Production Co. Ltd., Succeeded, on the world’s first attempt

Established by KOBAYASHI Yonesaku, a well-known documentary cameraman and pioneer of cinephotomicrography, and Dr ASAKA Tokio, anatomist and expert in biological sample research and development, Yone Production has played a vital role over 50 years in supporting scientific advancement and promoting scientific films. Venture Valuation (VV) interviewed FUJIEDA Ayumi, CEO. Read the Interview Would you … Continue reading Yone Production Co. Ltd., Succeeded, on the world’s first attempt

Read more

Workshop: Company Valuation for Fundraising – Trends & Tools

Venture Valuation held a workshop at the May 2021 edition of Biotechgate Digital Partnering, covering topics such as advice on speaking with investors and valuing a life science company with limited revenue – presented by Dr. Patrik Frei and Dr. Gergely Iványi on May 3rd, 2021. The full workshop can be viewed here, while slides … Continue reading Workshop: Company Valuation for Fundraising – Trends & Tools

Read more

Forty51 Ventures, newly established venture capital firm

April 2021: Started in Basel by three experienced Partners, Forty51 Ventures targets seed and early-stage investments in underfunded Biotech clusters in Switzerland, Germany, Eastern France, Northern Italy, and Austria. Venture Valuation (VV) interviewed Sascha Oliver Bucher, Co-Founder and Partner. Read the Interview Would you like to be notified about new interviews, reports and other valuable … Continue reading Forty51 Ventures, newly established venture capital firm

Read more